Probiotics and Non-Organic Gastrointestinal Improvement

Wecare Probiotics

Status

Enrolling

Conditions

Gastrointestinal Function

Treatments

Dietary Supplement: Probiotic group

Study type

Interventional

Funder types

Industry

Identifiers

NCT07081100

WK20250716

Details and patient eligibility

About

To verify the improvement of gastrointestinal function in patients with non-organic gastrointestinal dysfunction after 4 weeks of intervention with compound probiotics.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Voluntarily sign the informed consent form and agree to participate in the study.
Ability to complete the study according to the trial protocol requirements.
Aged 18-65 years.
Clinical diagnosis of non-organic gastrointestinal dysfunction (e.g., functional dyspepsia, functional constipation) without other serious organic diseases.

Exclusion criteria

Use of drugs affecting intestinal flora (antibiotics, probiotics, intestinal mucosal protectants, herbal medicines, etc.) for >1 week within 1 month prior to screening.
Short-term use of products with functions similar to the investigational product, which may interfere with result interpretation.
Antibiotic use during the study period.
History of severe systemic diseases or malignancies.
Allergy to any ingredient in the compound probiotic freeze-dried powder used in the trial.
Pregnancy, lactation, or plans for pregnancy in the near future.
Inability to participate due to personal reasons.
Other conditions deemed unsuitable by the investigators.